Medpace Holdings, Inc. - Common Stock (NQ:MEDP)

692.68 UNCHANGED

Delayed Quote Updated: 4:00 PM EDT, Oct 28, 2026 Add to My Watchlist

Quote

Overview Detailed Quote Charting Historical Prices

News

All News News Headlines Press Releases

Research

Quarterly Reports Insider Filings Other Filings

All News about Medpace Holdings, Inc. - Common Stock

< Previous 1 2 3 4 5 6 7 8 9

...

17 18 Next >

5 revealing analyst questions from Medpace’s Q3 earnings call

October 23, 2026

Medpace’s third quarter saw steady growth, with management attributing performance to robust demand for clinical research services and a healthy pipeline of ...

Via StockStory

Topics Earnings

Medpace: 3 Key Takeaways for Long-Term Investors ↗

October 23, 2026

Cancellations now stem from clinical failures rather than funding shortages, signaling a healthier market for contract research.

Via The Motley Fool

Topics Death Earnings

Medpace (MEDP) Q3 2026 Earnings Call Transcript ↗

October 22, 2026

Record net new business awards and 23.7% net income growth signal strong momentum.

Via The Motley Fool

Topics Earnings

Medpace (NASDAQ:MEDP) Q3 Revenue In Line and EPS Beat Offset by Cautious Sales Guidance ↗

October 21, 2026

Via Chartmill

Medpace Holdings (NASDAQ:MEDP) Jumps 17% After Q2 Earnings Beat and Raised Guidance ↗

July 22, 2026

Via Chartmill

Topics Earnings

MEDP Q3 deep dive: bookings strength drives growth, margin expansion continues

October 22, 2026

Clinical research company Medpace Holdings (NASDAQ:MEDP) met Wall Street’s revenue expectations in Q3 2026, with sales up 8.5% year on year to $716 million. ...

Via StockStory

Medpace Q3 Earnings Call Highlights ↗

October 22, 2026

Medpace (NASDAQ:MEDP) reported third-quarter 2026 revenue growth of 8.5% and record net new business awards, while management said the clinical research organization continues to see a strong operating...

Via MarketBeat

Topics Earnings

Medpace (NASDAQ:MEDP) reports Q3 2026 in line with expectations

October 21, 2026

Clinical research company Medpace Holdings (NASDAQ:MEDP) met Wall Street’s revenue expectations in Q3 2026, with sales up 8.5% year on year to $716 million. ...

Via StockStory

Medpace Holdings, Inc. Reports Third Quarter 2026 Results

October 21, 2026

From Medpace Holdings, Inc.

Via Business Wire

What To Expect From Medpace’s (MEDP) Q3 Earnings

October 19, 2026

Clinical research company Medpace Holdings (NASDAQ:MEDP) will be announcing earnings results this Wednesday after the bell. Here’s what you need to know. Med...

Via StockStory

1 Momentum Stock Worth Investigating and 2 Facing Headwinds

October 05, 2026

The stocks in this article are all trading near their 52-week highs. This strength often reflects positive developments such as new product launches, favorab...

Via StockStory

3 Market-Beating Stocks with Promising Prospects

September 23, 2026

Companies that consistently increase their sales, margins, or returns on capital are usually rewarded with the best returns, and those that can do all three ...

Via StockStory

Topics Energy

Medpace Holdings, Inc. to Report Third Quarter 2026 Financial Results on October 21, 2026

September 22, 2026

From Medpace Holdings, Inc.

Via Business Wire

1 Volatile Stock with Solid Fundamentals and 2 Facing Challenges

September 18, 2026

Volatility cuts both ways - while it creates opportunities, it also increases risk, making sharp declines just as likely as big gains. This unpredictability ...

Via StockStory

Topics Supply Chain

Here’s How Much You Would Have Made Owning Medpace Holdings Stock In The Last 5 Years ↗

September 11, 2026

Medpace Holdings (NASDAQ:MEDP) has outperformed the market over the past 5 years by 15.31% on an annualized basis producing an average annual return of 26.82%. Currently, Medpace Holdings has a market...

Via Benzinga

2 Healthcare Stocks with Competitive Advantages and 1 We Question

September 09, 2026

Healthcare companies are pushing the status quo by innovating in areas like drug development and digital health. Those leading the charge have not only reali...

Via StockStory

Innventure Announces Board Leadership Changes to Further Enhance Board Independence and Acceleration of CEO Transition

August 31, 2026

From Innventure, Inc.

Via GlobeNewswire

Medpace (MEDP): Buy, Sell, or Hold Post Q2 Earnings?

August 27, 2026

Medpace currently trades at $610.21 and has been a dream stock for shareholders. It’s returned 238% since August 2021, more than tripling the S&P 500’s 70.1%...

Via StockStory

Topics Stocks

If You Invested $1000 In Medpace Holdings Stock 10 Years Ago, You Would Have This Much Today ↗

August 26, 2026

Medpace Holdings (NASDAQ:MEDP) has outperformed the market over the past 10 years by 22.9% on an annualized basis producing an average annual return of 36.28%. Currently, Medpace Holdings has a market...

Via Benzinga

What Investors Should Know About Medpace CEO Troendle Selling $10 Million in Stock ↗

August 26, 2026

Troendle retains a $3.27 billion combined stake, representing 19% of the market cap, with the majority of holdings controlled through Medpace Investors, LLC.

Via The Motley Fool

Topics Regulatory Compliance

If You Invested $100 In Medpace Holdings Stock 5 Years Ago, You Would Have This Much Today ↗

August 14, 2026

Medpace Holdings (NASDAQ:MEDP) has outperformed the market over the past 5 years by 14.56% on an annualized basis producing an average annual return of 26.38%. Currently, Medpace Holdings has a market...

Via Benzinga

Drug Development Inputs & Services Stocks Q2 Recap: Benchmarking Medpace (NASDAQ:MEDP)

August 13, 2026

As the Q2 earnings season comes to a close, it’s time to take stock of this quarter’s best and worst performers in the drug development inputs & services ind...

Via StockStory

2 Mid-Cap Stocks Worth Your Attention and 1 We Question

August 13, 2026

Many investors pay attention to mid-cap stocks because they have established business models and expansive market opportunities. However, their paths to beco...

Via StockStory

3 High-Flying Stocks with Solid Fundamentals

August 03, 2026

Expensive stocks often command premium valuations because the market thinks their business models are exceptional. However, the downside is that high expecta...

Via StockStory

3 Cash-Heavy Stocks on Our Watchlist

July 31, 2026

Companies with more cash than debt often have stronger financial flexibility, making them attractive in uncertain markets. With interest payments less of a w...

Via StockStory

2 Momentum Stocks with Exciting Potential and 1 We Question

July 24, 2026

Exciting developments are taking place for the stocks in this article. They’ve all surged ahead of the broader market over the last month as catalysts such a...

Via StockStory

Why Is Medpace (MEDP) Stock Soaring Today

July 23, 2026

What Happened? Shares of clinical research company Medpace Holdings (NASDAQ:MEDP) jumped 14.4% in the afternoon session after the company reported second-qua...

Via StockStory

Medpace Q2 Earnings Call Highlights ↗

July 23, 2026

Medpace (NASDAQ:MEDP) reported double-digit growth in second-quarter revenue and earnings, while management described the business environment as strong and said lower cancellations helped drive record...

Via MarketBeat

Topics Earnings

The market is filled with gapping stocks in Thursday's session. ↗

July 23, 2026

Via Chartmill

Which stocks are moving before the opening bell on Thursday? ↗

July 23, 2026

Via Chartmill

< Previous 1 2 3 4 5 6 7 8 9

...

17 18 Next >

Stock Quote API & Stock News API supplied by www.cloudquote.io. Quotes delayed at least 20 minutes. Market data may be delayed. Research information, not personalized advice.